About Steminent

以創新科技帶來美好生活，提供更好的方式治療疾病
Better ways to treat diseases, bringing innovation to promote wonderful life

 

仲恩生醫科技股份有限公司是一間國際領先的幹細胞生物製藥公司，公司總部位於台北，並且在美國聖地牙哥設有分公司。仲恩具有穩定和高效率的幹細胞平台技術，目標在開發活細胞藥物以治療退化性疾病以及急性並且危及生命的疾病。

Steminent Biotherapeutics Inc. is a world leading biopharmaceutical company with operations in Taipei and San Diego. With our established cellular platform and technologies, we aimed to develop novel living cellular therapeutics for degenerative diseases and acute, life-threatening diseases.

仲恩希望將其幹細胞平台技術轉化成幹細胞治療藥物，並通過全球合作伙伴推進該細胞藥物在臨床應用的潛力。我們的最終目標是為患者、醫療從業者、合作夥伴以及股東帶來價值。

Steminent seeks to translate our evidence-based technology platform into numerous cellular therapeutic candidates and to advance the clinical potentials through global partnering initiatives. Our ultimate goal is to bring the values to the patients, medical practitioners, our partners as well as shareholders.